Although tumor-associated antigens, such as CEA, CA72-4, and CA50, found on the surface of GC cells can be used as markers for early GC screening, their limitations include high rates of false positive and negative results, poor specificity, and low sensitivity. This evidence concerns the gene CEACAM5 and neoplasm.